How to buy NanoVibronix stock (NAOV)

NanoVibronix is a medical devices business based in the US. NanoVibronix shares (NAOV) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.64 – a decrease of 8.39% over the previous week. NanoVibronix employs 10 staff and has a trailing 12-month revenue of around $3.4 million.

Our top picks for where to buy NanoVibronix stock

Buy NanoVibronix stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

NanoVibronix stock price (NASDAQ: NAOV)

Use our graph to track the performance of NAOV stocks over time.

NanoVibronix shares at a glance

• Key figures

Information last updated 2024-12-12.

Latest market close	$0.64
52-week range	$0.46 - $1.52
50-day moving average more info button	$0.62
200-day moving average more info button	$0.72
Wall St. target price	$10.50
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-1.23

Is it a good time to buy NanoVibronix stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NanoVibronix price performance over time

Historical closes compared with the close of $0.6148 from 2024-12-13

1 week (2024-12-11)	2.47%
1 month (2024-11-18)	-9.46%
3 months (2024-09-18)	-11.88%
6 months (2024-06-18)	-16.07%

1 year (2023-12-18)	-33.90%
2 years (2022-12-16)	-90.68%
3 years (2021-12-17)	20
5 years (2019-12-18)	57.2

NanoVibronix financials

Revenue TTM	$3.4 million
Gross profit TTM	$167,000
Return on assets TTM	-29.57%
Return on equity TTM	-140.59%
Profit margin	-83.49%
Book value	$1.95
Market Capitalization more info button	$2.3 million

TTM: trailing 12 months

NanoVibronix share dividends

We're not expecting NanoVibronix to pay a dividend over the next 12 months.

Have NanoVibronix's shares ever split?

NanoVibronix's shares were split on a 1:20 basis on 8 February 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NanoVibronix shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for NanoVibronix shares which in turn could have impacted NanoVibronix's share price.

NanoVibronix share price volatility

Over the last 12 months, NanoVibronix's shares have ranged in value from as little as $0.4575 up to $1.52. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NanoVibronix's is 1.512. This would suggest that NanoVibronix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

NanoVibronix overview

NanoVibronix, Inc. , through its subsidiary, NanoVibronix Ltd. , focuses on the non-invasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy in the United States, Israel, Europe, Australia, India, and internationally. The company's product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. It also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements. The company was incorporated in 2003 and is headquartered in Tyler, Texas.

Frequently asked questions

What percentage of NanoVibronix is owned by insiders or institutions?
Currently 0.693% of NanoVibronix shares are held by insiders and 13.49% by institutions. How many people work for NanoVibronix?
Latest data suggests 10 work at NanoVibronix. When does the fiscal year end for NanoVibronix?
NanoVibronix's fiscal year ends in December. Where is NanoVibronix based?
NanoVibronix's address is: 969 Pruitt Avenue, Tyler, TX, United States, 77569 What is NanoVibronix's ISIN number?
NanoVibronix's international securities identification number is: US63008J1088 What is NanoVibronix's CUSIP number?
NanoVibronix's Committee on Uniform Securities Identification Procedures number is: 63008J207